Science Explorer Back to mapMap
Discussion
Researcher · Sumitomo Dainippon Pharma (Japan) · Japan

Hitoshi Ban

Hitoshi Ban publishes mostly in Organic Chemistry, Molecular Biology and Radiology, Nuclear Medicine and Imaging, on topics such as Monoclonal and Polyclonal Antibodies Research, Chemical Synthesis and Analysis and Cancer, Lipids, and Metabolism.

OpenAlex
World rank
#3,099,171
of 7,710,434 ranked researchers
Rank in Japan
#70,529
of 383,136
Works
37
Citations
1.1k
Citations per work
28.7
h-index
12
i10-index 14Top 51% in Organic Chemistry
Hitoshi Ban

What does Hitoshi Ban research?

Hitoshi Ban's work is mostly in Biochemistry, Genetics and Molecular Biology (32%), Chemistry (23%), Medicine (15%).

Life Sciences: 14 works · 37.7% of their workBiochemistry, Genetics and Molecular Biology: 12 works · 32.0% of their workMolecular Biology: 8 works · 22.6% of their workCancer Research: 3 works · 9.4% of their workImmunology and Microbiology: 2 works · 5.7% of their workImmunology: 2 works · 5.7% of their workEverything else: 9 works · 24.6% of their workPhysical Sciences: 8 works · 22.6% of their workChemistry: 8 works · 22.6% of their workOrganic Chemistry: 8 works · 22.6% of their workHealth Sciences: 6 works · 15.1% of their workMedicine: 6 works · 15.1% of their workRadiology, Nuclear Medicine and Imaging: 3 works · 9.4% of their workSurgery: 2 works · 5.7% of their workTHEIR WORKHitoshi Ban37works
Life Sciences38%Physical Sciences23%Health Sciences15%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology1232.0%
    2. Immunology and Microbiology25.7%
  2. Everything else924.6%
    1. Chemistry822.6%
    1. Medicine615.1%
  1. 1Organic Chemistry23% of their works
  2. 2Molecular Biology23% of their works
  3. 3Radiology, Nuclear Medicine and Imaging9% of their works
  4. 4Cancer Research9% of their works
  5. 5Surgery6% of their works
  6. 6Immunology6% of their works

Research topics

Which keywords describe Hitoshi Ban's research?

The keywords of their largest research topics: Drug Discovery, Cholesterol, Fc Receptors, Therapeutic Antibodies, Foldamers, Peptide Synthesis, Fatty Acid Synthase and Lipid Metabolism.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Drug Discovery102 topics
  2. Cholesterol92 topics
  3. Fc Receptors71 topic
  4. Therapeutic Antibodies71 topic
  5. Foldamers61 topic
  6. Peptide Synthesis61 topic
  7. Fatty Acid Synthase51 topic
  8. Lipid Metabolism51 topic
  9. Atherosclerosis41 topic
  10. Click Chemistry41 topic
  11. Copper-Catalyzed Cycloaddition41 topic
  12. Metabolism41 topic
  13. Alkaloids31 topic
  14. Amaryllidaceae31 topic
  15. Dendritic Cells31 topic
  16. HIF-131 topic
  17. Immunity31 topic
  18. Warburg Effect31 topic

Where does Hitoshi Ban work?

Hitoshi Ban's main affiliation in the publication record is Sumitomo Dainippon Pharma (Japan), Japan.

How many publications and citations does Hitoshi Ban have?

OpenAlex counts 37 works and 1,062 citations for Hitoshi Ban, an h-index of 12, ranking #3,099,171 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Hitoshi Ban. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.